Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$183M |
| 3 |
Target
TGT
|
+$175M |
| 4 |
American Electric Power
AEP
|
+$174M |
| 5 |
NextEra Energy
NEE
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$6.19B |
| 2 |
Coty
COTY
|
+$1.11B |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.41% |
| 2 | Financials | 12.33% |
| 3 | Energy | 10.93% |
| 4 | Industrials | 10.41% |
| 5 | Technology | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
GSK
GSK
$105B
| $77.1M | 0.16% |
1,601,309
+1,021,508
| +176% | +$50.5M |
|
152
Cboe Global Markets
CBOE
$31.4B
| $76.7M | 0.16% |
1,038,436
+211,148
| +26% | +$14.5M |
|
|
PRAH
153
DELISTED
PRA Health Sciences, Inc.
PRAH
| $76.7M | 0.16% |
1,391,995
+703,301
| +102% | +$38.6M |
|
|
MON
154
DELISTED
Monsanto Co
MON
| $76.2M | 0.16% |
724,486
-870,075
| -55% | -$89.2M |
|
|
CIT
155
DELISTED
CIT Group Inc.
CIT
| $75.4M | 0.16% |
1,766,623
+1,562,424
| +765% | +$61.5M |
|
156
Eastman Chemical
EMN
$8.47B
| $74.4M | 0.16% |
988,645
+430,461
| +77% | +$31.1M |
|
|
HRC
157
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $73.8M | 0.15% |
1,314,388
+512,788
| +64% | +$29.1M |
|
|
FMSA
158
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $73.7M | 0.15% |
6,252,492
+575,606
| +10% | +$5.32M |
|
159
Colgate-Palmolive
CL
$72.6B
| $73.4M | 0.15% |
1,121,678
+415,950
| +59% | +$28.5M |
|
160
Moody's
MCO
$87.2B
| $73.4M | 0.15% |
778,483
+725,544
| +1,371% | +$73.2M |
|
|
NFX
161
DELISTED
Newfield Exploration
NFX
| $73.4M | 0.15% |
1,811,764
+1,194,070
| +193% | +$50.7M |
|
162
Xerox
XRX
$381M
| $73.3M | 0.15% |
3,184,525
+2,464,941
| +343% | +$61.4M |
|
163
Best Buy
BBY
$18.1B
| $73.1M | 0.15% |
1,712,833
-110,769
| -6% | -$4.71M |
|
164
Honeywell
HON
$68.4B
| $73M | 0.15% |
697,952
+453,893
| +186% | +$46.2M |
|
165
Viasat
VSAT
$10.3B
| $72.9M | 0.15% |
1,101,247
+599,402
| +119% | +$43M |
|
|
HR
166
DELISTED
Healthcare Realty Trust Incorporated
HR
| $72.9M | 0.15% |
2,403,480
+37,088
| +2% | +$1.13M |
|
167
Ovintiv
OVV
$18.5B
| $72.7M | 0.15% |
1,238,602
-2,625,603
| -68% | -$150M |
|
|
SYNH
168
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $72.2M | 0.15% |
1,372,445
+898,493
| +190% | +$43.5M |
|
|
BDN
169
Brandywine Realty Trust
BDN
$522M
| $71.7M | 0.15% |
4,342,637
+3,310,742
| +321% | +$50.7M |
|
170
Targa Resources
TRGP
$64.1B
| $71.5M | 0.15% |
1,274,564
-941,702
| -42% | -$47.6M |
|
|
BERY
171
DELISTED
Berry Global Group, Inc.
BERY
| $70.5M | 0.15% |
1,574,921
+754,770
| +92% | +$32.3M |
|
172
CubeSmart
CUBE
$9.21B
| $70.2M | 0.15% |
2,623,014
+1,935,556
| +282% | +$49.6M |
|
|
QGENF
173
DELISTED
QIAGEN NV
QGENF
| $69.6M | 0.15% |
2,482,273
-224,024
| -8% | -$6.28M |
|
174
Zoetis
ZTS
$32.1B
| $69.2M | 0.14% |
1,292,515
-431,755
| -25% | -$22M |
|
175
Hubbell
HUBB
$24.8B
| $68.9M | 0.14% |
590,297
+376,149
| +176% | +$41.3M |
|
Similar funds
Israel Englander's Q4 2016 Portfolio in Review
As of Q4 2016, Israel Englander held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Israel Englander withdrew a net $13B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Financials and Energy.
Against the trend, Israel Englander opened a new position in Target worth $175M.
- Israel Englander's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
- Israel Englander added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
- Israel Englander's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
- Israel Englander fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
- Israel Englander's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
- Israel Englander opened 858 new positions and closed 801 in Q4 2016.
- Israel Englander's portfolio value fell 20% quarter-over-quarter to $47.8B.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.